⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RGNX News
REGENXBIO Inc.
REGENXBIO Announces Alignment with FDA on Path Forward for NAVSUNLI™ BLA Resubmission for Accelerated Approval; First Potential Gene Therapy for MPS II
prnewswire.com
RGNX
Lifshitz Law PLLC Announces Investigations of BlackRock, TCP Capital Corp. (NASDAQ: TCPC), Oracle Corporation (NYSE: ORCL), REGENXBIO Inc. (NASDAQ: RGNX), and Inovio Pharmaceuticals, Inc. (NASDAQ: INO)
accessnewswire.com
TCPC
ORCL
RGNX
INO
Form 8-K
sec.gov
RGNX
REGENXBIO to Participate in Upcoming Investor Conferences
prnewswire.com
RGNX
Form 8-K
sec.gov
RGNX
REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights
prnewswire.com
RGNX
REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202
prnewswire.com
RGNX
FORE Biotherapeutics to Participate in Upcoming Investor Conferences
businesswire.com
RGNX
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting
prnewswire.com
RGNX
Catalyst Monitor: Q2 2026 Outlook Report - Trial Initiations, Completions, Top-line Results, Regulatory Filings, PDUFA Dates, and Expected Approvals
globenewswire.com
RPTX
ARVN
RGNX